These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8062517)

  • 1. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus.
    Smulders RA; Stehouwer CD; Olthof CG; van Kamp GJ; Teerlink T; de Vries PM; Donker AJ
    Clin Sci (Lond); 1994 Jul; 87(1):37-43. PubMed ID: 8062517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects: L-arginine-induced vasodilatation cannot be explained by non-specific effects of cationic amino acids.
    Smulders RA; Aarsen M; Teerlink T; De Vries PM; Van Kamp GJ; Donker AJ; Stehouwer CD
    Clin Sci (Lond); 1997 Apr; 92(4):367-74. PubMed ID: 9176035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of insulin infusion on endothelium-derived vasoactive substances.
    Polderman KH; Stehouwer CD; van Kamp GJ; Gooren LJ
    Diabetologia; 1996 Nov; 39(11):1284-92. PubMed ID: 8932993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels.
    Piatti P; Fragasso G; Monti LD; Setola E; Lucotti P; Fermo I; Paroni R; Galluccio E; Pozza G; Chierchia S; Margonato A
    Circulation; 2003 Jan; 107(3):429-36. PubMed ID: 12551867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal, obese and type 2 diabetic subjects.
    Ferlito S; Gallina M
    Minerva Endocrinol; 2000 Jun; 25(2):33-7. PubMed ID: 11189789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
    Cassone Faldetta M; Laurenti O; Desideri G; Bravi MC; De Luca O; Marinucci MC; De Mattia G; Ferri C
    Diabetologia; 2002 Aug; 45(8):1120-7. PubMed ID: 12189442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
    Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
    Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of nitric oxide pathway to L-arginine infusion at the altitude of 4,350 m.
    Schneider JC; Blazy I; Déchaux M; Rabier D; Mason NP; Richalet JP
    Eur Respir J; 2001 Aug; 18(2):286-92. PubMed ID: 11529286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pressor, renal and endocrine effects of systemic infusion of L-arginine in hypertensive patients].
    Dell'Omo G; Catapano G; Ebel M; Gazzano A; Ducci M; Del Chicca M; Clerico A; Pedrinelli R
    Ann Ital Med Int; 1995; 10(2):107-12. PubMed ID: 7619649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired intrarenal dopamine production following intravenous sodium chloride infusion in type 1 (insulin-dependent) diabetes mellitus.
    Stenvinkel P; Saggar-Malik AK; Wahrenberg H; Diczfalusy U; Bolinder J; Alvestrand A
    Diabetologia; 1991 Feb; 34(2):114-8. PubMed ID: 1829692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans.
    Higashi Y; Oshima T; Ono N; Hiraga H; Yoshimura M; Watanabe M; Matsuura H; Kambe M; Kajiyama G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2198-202. PubMed ID: 7608279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock.
    Weitzberg E; Rudehill A; Modin A; Lundberg JM
    Crit Care Med; 1995 May; 23(5):909-18. PubMed ID: 7736750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired vasodilator response to atrial natriuretic factor in IDDM.
    Smits P; Hersbach FM; Jansen TL; Thien T; Lutterman JA
    Diabetes; 1993 Oct; 42(10):1454-61. PubMed ID: 8397129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-arginine does not prevent the renal effects of endothelin in humans.
    Bijlsma JA; Rabelink AJ; Kaasjager KA; Koomans HA
    J Am Soc Nephrol; 1995 Jan; 5(7):1508-16. PubMed ID: 7703389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and stimulated plasma atrial natriuretic factor in type 2 diabetes.
    McKnight JA; Sheridan B; Roberts G; Atkinson AB
    Diabetes Res; 1991 Nov; 18(3):143-8. PubMed ID: 1841825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered microvascular reactivity to endothelin-1, endothelin-3 and NG-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus.
    Lawrence E; Brain SD
    Br J Pharmacol; 1992 Aug; 106(4):1035-40. PubMed ID: 1393277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.
    Tajiri K; Miyakawa H; Izumi N; Marumo F; Sato C
    Hepatology; 1995 Nov; 22(5):1430-5. PubMed ID: 7590659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related effect of intravenous L-arginine on muscular blood flow of the calf in patients with peripheral vascular disease: a H215O positron emission tomography study.
    Schellong SM; Böger RH; Burchert W; Bode-Böger SM; Galland A; Frölich JC; Hundeshagen H; Alexander K
    Clin Sci (Lond); 1997 Aug; 93(2):159-65. PubMed ID: 9301431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted effect of ANP on hematocrit and plasma volume in streptozotocin-induced diabetes mellitus in rats.
    Valentin JP; Sechi LA; Humphreys MH
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R584-91. PubMed ID: 8141419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
    Huvers FC; De Leeuw PW; Houben AJ; De Haan CH; Hamulyak K; Schouten H; Wolffenbuttel BH; Schaper NC
    Diabetes; 1999 Jun; 48(6):1300-7. PubMed ID: 10342820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.